Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.

Ulaner GA, Huang HY, Otero J, Zhao Z, Ben-Porat L, Satagopan JM, Gorlick R, Meyers P, Healey JH, Huvos AG, Hoffman AR, Ladanyi M.

Cancer Res. 2003 Apr 15;63(8):1759-63.

2.

Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.

Ulaner GA, Hoffman AR, Otero J, Huang HY, Zhao Z, Mazumdar M, Gorlick R, Meyers P, Healey JH, Ladanyi M.

Genes Chromosomes Cancer. 2004 Oct;41(2):155-62.

PMID:
15287028
3.

Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.

Villa R, Daidone MG, Motta R, Venturini L, De Marco C, Vannelli A, Kusamura S, Baratti D, Deraco M, Costa A, Reddel RR, Zaffaroni N.

Clin Cancer Res. 2008 Jul 1;14(13):4134-40. doi: 10.1158/1078-0432.CCR-08-0099.

4.

Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines.

Fujiwara-Akita H, Maesawa C, Honda T, Kobayashi S, Masuda T.

Int J Oncol. 2005 Apr;26(4):1009-16.

PMID:
15753996
5.

Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.

Scheel C, Schaefer KL, Jauch A, Keller M, Wai D, Brinkschmidt C, van Valen F, Boecker W, Dockhorn-Dworniczak B, Poremba C.

Oncogene. 2001 Jun 28;20(29):3835-44.

6.

Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.

Ohali A, Avigad S, Naumov I, Goshen Y, Ash S, Yaniv I.

Genes Chromosomes Cancer. 2008 Nov;47(11):965-70. doi: 10.1002/gcc.20600.

PMID:
18663749
7.

Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.

Costa A, Daidone MG, Daprai L, Villa R, Cantù S, Pilotti S, Mariani L, Gronchi A, Henson JD, Reddel RR, Zaffaroni N.

Cancer Res. 2006 Sep 1;66(17):8918-24.

8.

Telomerase expression predicts unfavorable outcome in osteosarcoma.

Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, Dome JS.

J Clin Oncol. 2004 Sep 15;22(18):3790-7.

PMID:
15365076
9.

A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.

Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE, Reddel RR.

Clin Cancer Res. 2005 Jan 1;11(1):217-25.

10.
11.

Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.

Gocha AR, Nuovo G, Iwenofu OH, Groden J.

Am J Pathol. 2013 Jan;182(1):41-8. doi: 10.1016/j.ajpath.2012.10.001.

12.

Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.

Venturini L, Daidone MG, Motta R, Collini P, Spreafico F, Terenziani M, Piva L, Radice P, Perotti D, Zaffaroni N.

Genes Chromosomes Cancer. 2011 Oct;50(10):823-9. doi: 10.1002/gcc.20903. Epub 2011 Jul 18.

PMID:
21769957
13.

ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.

Onda M, Matsuda S, Higaki S, Iijima T, Fukushima J, Yokokura A, Kojima T, Horiuchi H, Kurokawa T, Yamamoto T.

Cancer. 1996 Jan 1;77(1):71-8.

14.

Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter.

Hoare SF, Bryce LA, Wisman GB, Burns S, Going JJ, van der Zee AG, Keith WN.

Cancer Res. 2001 Jan 1;61(1):27-32.

15.

Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.

Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, Ulm K, Holzmann B, Nekarda H, Siewert JR.

J Clin Oncol. 2004 May 15;22(10):1807-14.

PMID:
15143073
16.

Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.

Zaffaroni N, Villa R, Pastorino U, Cirincione R, Incarbone M, Alloisio M, Curto M, Pilotti S, Daidone MG.

Clin Cancer Res. 2005 Apr 15;11(8):2832-9.

17.

Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.

Onitake Y, Hiyama E, Kamei N, Yamaoka H, Sueda T, Hiyama K.

J Pediatr Surg. 2009 Dec;44(12):2258-66. doi: 10.1016/j.jpedsurg.2009.07.046.

PMID:
20006006
18.

Analysis of telomerase activity and telomere length in bone and soft tissue tumors.

Terasaki T, Kyo S, Takakura M, Maida Y, Tsuchiya H, Tomita K, Inoue M.

Oncol Rep. 2004 Jun;11(6):1307-11.

PMID:
15138570
19.

Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance.

Venturini L, Daidone MG, Motta R, Cimino-Reale G, Hoare SF, Gronchi A, Folini M, Keith WN, Zaffaroni N.

Neuro Oncol. 2012 Jun;14(6):736-44. doi: 10.1093/neuonc/nos083. Epub 2012 Apr 19.

20.

High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.

Oh BK, Kim H, Park YN, Yoo JE, Choi J, Kim KS, Lee JJ, Park C.

Lab Invest. 2008 Feb;88(2):144-52. Epub 2007 Dec 24.

Supplemental Content

Support Center